FDA panel backs plan for annual COVID-19 booster, as new
An FDA panel endorsed the agency's plan for a once-a-year COVID-19 booster. And CDC data shows that XBB.1.5 continues to lead other variants in the U.S. Source
Closely Watched News
An FDA panel endorsed the agency's plan for a once-a-year COVID-19 booster. And CDC data shows that XBB.1.5 continues to lead other variants in the U.S. Source
The S&P 500 is on the verge of achieving its first “golden cross” in two-and-a-half years. But that doesn't mean stocks are destined for more gains over the… Source
Retail brokerage Charles Schwab late Wednesday publicly criticized the New York Stock Exchange for its handling of a trading glitch this week. Source
The U.S. faces tough odds to repeat its performance in 2023 as rising interest rates sap growth Source
U.S. economic calendar consensus forecasts from MarketWatch. Source
Orders for manufactured goods jumped 5.6% in December because of a flush of new contracts for Boeing passenger planes, but business investment was weak again… Source
U.S. stocks finish higher on Thursday as fourth-quarter gross domestic product came in slightly stronger than expected, boosting investor confidence that the… Source
New home sales at 616,000 annual rate in December versus 602,000 in prior month. Source